I listened. Sounded like all is approved for Merger. All systems go and new CEO Michael Handley said shares of “CYTO” should be trading “within days”…
A question came up about some “emergency use” potential and what that would mean for revenue and the question asked about margins on revenue in which the CEO said 80%. He said at these prices the company is valued at $200 Million (I think) and he went on to talk about all the pipeline of exciting things and what stages of clinical trials everything was in.
Market Data 
Markets 
AI
